Lv11
6 积分 2024-05-10 加入
食管癌寡转移放射治疗专家共识（2025年版）
3小时前
已完结
Cancer burden and control in China: landscape, trends and challenges
3小时前
已完结
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
3天前
已完结
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
10天前
已完结
复发转移性宫颈癌诊疗指南（2025版）
11天前
已完结
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
13天前
已完结
中华医学会肺癌临床诊疗指南（2025版）
14天前
已完结
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)
14天前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
14天前
已完结
皖公网安备34019202002308
